Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Lab-on-a-Chip Measures Mechanics of Bacteria Colonies

By LabMedica International staff writers
Posted on 06 Jul 2009
A microfluidic device, also known as a lab-on-a-chip, estimates biofilms resistance to pressure. More...
Biofilms experience various kinds of pressure in nature and in the body as they squeeze through capillaries and adhere to the surfaces of e.g., medical devices.

Most bacteria in nature form biofilms. Bacteria are single-celled organisms, but they rarely live alone, said John Younger, associate chair for research in the department of emergency medicine at the University of (U-M) Health System (UHMS; Ann Arbor, MI, USA). Prof. Younger is a coauthor of the study that forms the cover story of the July 7, 2009 edition of Langmuir.

To understand biofilms and their life cycle, it is necessary to consider their genetics as well as their mechanical properties. Biofilms are "materials that respond to forces, because how they live in the environment depends on that response," said Mike Solomon, associate professor of chemical engineering and macromolecular science and engineering, who is senior author of the paper.

The U-M microfluidic device provides the right scale. The channel-etched chip, made from a flexible polymer, allows scientists to study minute samples of between 50 and 500 bacterial cells that form biofilms of 10-50µ in size. Such small samples behave in the device as they do in the body. Tools that require larger samples do not always give an accurate picture of how a particular substance behaves on the smallest scales.

The biofilms studied had a greater elasticity than previous methods had measured. The scientists discovered a hardening response, which means that the more pressure applied to the biofilms, the more resistance the materials put forth.

Mechanical forces are set in motion when we defend ourselves against these bacterial colonies. Gene expression patterns can be studied indefinitely, but until it is known when the materials will bend or break and what the immune system has to do from a physical perspective, how to fight this opponent remains a mystery.

Experiments were performed on colonies of Staphylococcus epidermidis and Klebsiella pneumoniae, which are known to cause infections in hospitals. The new microfluidic device could also be used to measure the resistance of various other soft-solid materials in biomaterials, pharmaceutical fields, consumer products, and food science.

Related Links:
Department of Emergency Medicine at the University of Michigan Health System




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.